TranspireBio Completed Phase 1 Inhaler Study
The company met all clinical endpoints for its new Soft Mist Inhaler platform in a recent pharmacokinetic trial.
Live Poll
Do you believe advancements in medical delivery devices will improve patient access to treatments?